CLEOPATRA HOSPITAL COMPANY
CLHO

EGX

Current Price
EGP
EGP (%)
Price Upon Recommendation
7.65 EGP
Target Price from Recommendation

9.00 EGP

+17.60%
Holding Period

More than 12 months

Final Recommendation

Buy stock at the current price

Valid Until

April 15, 2026 at 11:59:59 PM

Risk Assessment

Medium

Confidence Score

75.00%

Potential Growth

17.60%

Investment Reason

CLHO is positioned to benefit from Egypt's economic reforms and increased foreign investment, supported by its strong fundamentals and alignment with EGX 30's upward trajectory .

Overview
Recent Performance

CLHO has shown resilience amid market fluctuations, with a 30-day gain of 8.64% in line with the EGX 30's growth .

Economic Factors

Egypt's inflation-driven market rallies and EGX's liquidity improvements enhance CLHO's growth prospects .

Competitive Positioning

CLHO operates in high-demand sectors with limited competition, leveraging strategic partnerships and regulatory support .

Analysis Summary

CLHO's alignment with Egypt's economic momentum, coupled with its strong market positioning, makes it a compelling buy for growth-oriented investors.

Key Points
  • EGX 30 alignment drives CLHO's liquidity and growth.
  • 17.6% upside potential with a target price of 9.00 EGP.
  • Resilient performance amid regional economic shifts.
  • Strategic positioning in high-demand sectors.
Recommendations